{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T02:50:58Z","timestamp":1777517458398,"version":"3.51.4"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2021,1,10]],"date-time":"2021-01-10T00:00:00Z","timestamp":1610236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,10]],"date-time":"2021-01-10T00:00:00Z","timestamp":1610236800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100002767","name":"Hunan Provincial Science and Technology Department","doi-asserted-by":"publisher","award":["2019SK1010"],"award-info":[{"award-number":["2019SK1010"]}],"id":[{"id":"10.13039\/501100002767","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1007\/s00228-020-03080-y","type":"journal-article","created":{"date-parts":[[2021,1,10]],"date-time":"2021-01-10T01:49:53Z","timestamp":1610243393000},"page":"999-1009","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Population pharmacokinetics of unbound valproic acid in pediatric epilepsy patients in China: a protein binding model"],"prefix":"10.1007","volume":"77","author":[{"given":"Xurui","family":"Gu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changcheng","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuran","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qilin","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mubai","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yani","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziran","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheng","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4776-9522","authenticated-orcid":false,"given":"Boting","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,10]]},"reference":[{"issue":"10172","key":"3080_CR1","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/S0140-6736(18)32596-0","volume":"393","author":"RD Thijs","year":"2019","unstructured":"Thijs RD, Surges R, O'Brien TJ, Sander JW (2019) Epilepsy in adults. Lancet 393(10172):689\u2013701","journal-title":"Lancet"},{"issue":"1\u20132","key":"3080_CR2","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.eplepsyres.2013.02.002","volume":"105","author":"L Gu","year":"2013","unstructured":"Gu L, Liang B, Chen Q, Long J, Xie J, Wu G, Yan Y, Tan J, Dou W, Chen W, Wu P, Wang J, Su L (2013) Prevalence of epilepsy in the People\u2019s republic of China: a systematic review. Epilepsy Res 105(1\u20132):195\u2013205","journal-title":"Epilepsy Res"},{"issue":"6","key":"3080_CR3","doi-asserted-by":"publisher","first-page":"BSR20181654","DOI":"10.1042\/BSR20181654","volume":"38","author":"ZJ Wang","year":"2018","unstructured":"Wang ZJ, Chen J, Chen HL, Zhang LY, Xu D, Jiang WT (2018) Association between SCN1A polymorphism rs3812718 and valproic acid resistance in epilepsy children: a case-control study and meta-analysis. Biosci Rep 38(6):BSR20181654","journal-title":"Biosci Rep"},{"issue":"Suppl 9","key":"3080_CR4","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1111\/j.1528-1167.2005.00322.x","volume":"46","author":"C Camfield","year":"2005","unstructured":"Camfield C, Camfield P (2005) Management guidelines for children with idiopathic generalized epilepsy. Epilepsia 46(Suppl 9):112\u2013116","journal-title":"Epilepsia"},{"issue":"4","key":"3080_CR5","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1212\/WNL.52.4.889-a","volume":"52","author":"FK Alehan","year":"1999","unstructured":"Alehan FK, Morton LD, Pellock JM (1999) Treatment of absence status with intravenous valproate. Neurology 52(4):889\u2013890","journal-title":"Neurology"},{"issue":"3","key":"3080_CR6","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1056\/NEJM199601183340308","volume":"334","author":"MJ Brodie","year":"1996","unstructured":"Brodie MJ, Dichter MA (1996) Antiepileptic drugs. N Engl J Med 334(3):168\u2013175","journal-title":"N Engl J Med"},{"issue":"1","key":"3080_CR7","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s40263-015-0304-5","volume":"30","author":"AM Cook","year":"2016","unstructured":"Cook AM, Zafar MS, Mathias S, Stewart AM, Albuja AC, Bensalem-Owen M, Kapoor S, Baumann RJ (2016) Pharmacokinetics and clinical utility of valproic acid administered via continuous infusion. CNS Drugs 30(1):71\u201377","journal-title":"CNS Drugs"},{"issue":"1","key":"3080_CR8","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1097\/00007691-199202000-00009","volume":"14","author":"Y Kodama","year":"1992","unstructured":"Kodama Y, Koike Y, Kimoto H, Yasunaga F, Takeyama M, Teraoka I, Fujii I (1992) Binding parameters of valproic acid to serum protein in healthy adults at steady state. Ther Drug Monit 14(1):55\u201360","journal-title":"Ther Drug Monit"},{"issue":"6","key":"3080_CR9","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1038\/clpt.1985.116","volume":"37","author":"LA Bauer","year":"1985","unstructured":"Bauer LA, Davis R, Wilensky A, Raisys V, Levy RH (1985) Valproic acid clearance: unbound fraction and diurnal variation in young and elderly adults. Clin Pharmacol Ther 37(6):697\u2013700","journal-title":"Clin Pharmacol Ther"},{"issue":"12","key":"3080_CR10","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1038\/nrd3287","volume":"9","author":"DA Smith","year":"2010","unstructured":"Smith DA, Di L, Kerns EH (2010) The effect of plasma protein binding on in vivo efficacy: misconceptions in drug discovery. Nat Rev Drug Discov 9(12):929\u2013939","journal-title":"Nat Rev Drug Discov"},{"issue":"3","key":"3080_CR11","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1097\/FTD.0000000000000405","volume":"39","author":"E Wallenburg","year":"2017","unstructured":"Wallenburg E, Klok B, de Jong K, de Maat M, van Erp N, Stalpers-Konijnenburg S, Essink G, van Luin M (2017) Monitoring protein-unbound valproic acid serum concentrations in clinical practice. Ther Drug Monit 39(3):269\u2013272","journal-title":"Ther Drug Monit"},{"key":"3080_CR12","doi-asserted-by":"publisher","first-page":"113475","DOI":"10.1016\/j.ab.2019.113475","volume":"588","author":"X Gu","year":"2020","unstructured":"Gu X, Yu S, Peng Q, Ma M, Hu Y, Zhou B (2020) Determination of unbound valproic acid in plasma using centrifugal ultrafiltration and gas chromatography: application in TDM. Anal Biochem 588:113475","journal-title":"Anal Biochem"},{"issue":"8","key":"3080_CR13","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1002\/phar.1965","volume":"37","author":"M Dor\u00e9","year":"2017","unstructured":"Dor\u00e9 M, San Juan AE, Frenette AJ, Williamson D (2017) Clinical importance of monitoring unbound valproic acid concentration in patients with hypoalbuminemia. Pharmacotherapy 37(8):900\u2013907","journal-title":"Pharmacotherapy"},{"issue":"2","key":"3080_CR14","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1345\/aph.19147","volume":"34","author":"JA Haroldson","year":"2000","unstructured":"Haroldson JA, Kramer LE, Wolff DL, Lake KD (2000) Elevated free fractions of valproic acid in a heart transplant patient with hypoalbuminemia. Ann Pharmacother 34(2):183\u2013187","journal-title":"Ann Pharmacother"},{"issue":"1","key":"3080_CR15","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1525-139X.2005.18106.x","volume":"18","author":"Z Al Aly","year":"2005","unstructured":"Al Aly Z, Yalamanchili P, Gonzalez E (2005) Extracorporeal management of valproic acid toxicity: a case report and review of the literature. Semin Dial 18(1):62\u201366","journal-title":"Semin Dial"},{"issue":"1","key":"3080_CR16","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/j.1365-2710.2008.00885.x","volume":"33","author":"S Ueshima","year":"2008","unstructured":"Ueshima S, Aiba T, Makita T, Nishihara S, Kitamura Y, Kurosaki Y, Kawasaki H, Sendo T, Ohtsuka Y, Gomita Y (2008) Characterization of non-linear relationship between total and unbound serum concentrations of valproic acid in epileptic children. J Clin Pharm Ther 33(1):31\u201338","journal-title":"J Clin Pharm Ther"},{"issue":"6","key":"3080_CR17","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1007\/s00228-018-2444-2","volume":"74","author":"C Rodrigues","year":"2018","unstructured":"Rodrigues C, Chhun S, Chiron C, Dulac O, Rey E, Pons G, Jullien V (2018) A population pharmacokinetic model taking into account protein binding for the sustained-release granule formulation of valproic acid in children with epilepsy. Eur J Clin Pharmacol 74(6):793\u2013803","journal-title":"Eur J Clin Pharmacol"},{"issue":"2","key":"3080_CR18","first-page":"61","volume":"90","author":"MS Mostafa","year":"2017","unstructured":"Mostafa MS, Elshafie HS, Ghaleb S (2017) A rapid and simple procedure for monitoring valproic acid by gas chromatography. J Biol Res-Boll Soc Biol Sper 90(2):61\u201365","journal-title":"J Biol Res-Boll Soc Biol Sper"},{"issue":"9","key":"3080_CR19","first-page":"629","volume":"38","author":"G Bano","year":"1990","unstructured":"Bano G, Gupta S, Gupta KL, Raina RK (1990) Pharmacokinetics of valproic acid after administration of three oral formulations in healthy adults. J Assoc Physicians India 38(9):629\u2013630","journal-title":"J Assoc Physicians India"},{"key":"3080_CR20","unstructured":"Jiao Z, Zhong M, Hu M, Shi X, Li Z, Zhang J et al (2009) Population pharmacokinetic modeling of valproic acid clearance. Chin Hosp Pharm J 9:515\u2013518\u00a0[in Chinese]"},{"key":"3080_CR21","unstructured":"Li H, Ji CY, Zong XN, Zhang YQ: [Height and weight standardized growth charts for Chinese children and adolescents aged 0 to 18 years]. Zhonghua er ke za zhi = Chinese journal of pediatrics 2009, 47(7):487\u2013492"},{"issue":"1","key":"3080_CR22","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s40262-018-0667-0","volume":"58","author":"J Sinha","year":"2019","unstructured":"Sinha J, Al-Sallami HS, Duffull SB (2019) Choosing the allometric exponent in covariate model building. Clin Pharmacokinet 58(1):89\u2013100","journal-title":"Clin Pharmacokinet"},{"issue":"1","key":"3080_CR23","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1002\/cpt.1791","volume":"108","author":"L Gibiansky","year":"2020","unstructured":"Gibiansky L, Ravva P, Parrott NJ, Bhardwaj R, Zwanziger E, Grimsey P, Clinch B, Sturm S (2020) Mechanistic population pharmacokinetic model of oseltamivir and oseltamivir carboxylate accounting for physiological changes to predict exposures in neonates and infants. Clin Pharmacol Ther 108(1):126\u2013135","journal-title":"Clin Pharmacol Ther"},{"issue":"3","key":"3080_CR24","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1111\/j.1460-9592.2010.03364.x","volume":"21","author":"BJ Anderson","year":"2011","unstructured":"Anderson BJ, Larsson P (2011) A maturation model for midazolam clearance. Paediatr Anaesth 21(3):302\u2013308","journal-title":"Paediatr Anaesth"},{"key":"3080_CR25","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.ejps.2018.06.033","volume":"122","author":"S Xu","year":"2018","unstructured":"Xu S, Chen Y, Zhao M, Guo Y, Wang Z, Zhao L (2018) Population pharmacokinetics of valproic acid in epileptic children: effects of clinical and genetic factors. Eur J Pharm Sci 122:170\u2013178","journal-title":"Eur J Pharm Sci"},{"issue":"3","key":"3080_CR26","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s40262-014-0212-8","volume":"54","author":"J Ding","year":"2015","unstructured":"Ding J, Wang Y, Lin W, Wang C, Zhao L, Li X, Zhao Z, Miao L, Jiao Z (2015) A population pharmacokinetic model of valproic acid in pediatric patients with epilepsy: a non-linear pharmacokinetic model based on protein-binding saturation. Clin Pharmacokinet 54(3):305\u2013317","journal-title":"Clin Pharmacokinet"},{"issue":"5","key":"3080_CR27","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1111\/j.1365-2125.1989.tb03548.x","volume":"28","author":"IA Choonara","year":"1989","unstructured":"Choonara IA, McKay P, Hain R, Rane A (1989) Morphine metabolism in children. Br J Clin Pharmacol 28(5):599\u2013604","journal-title":"Br J Clin Pharmacol"},{"issue":"5","key":"3080_CR28","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1124\/dmd.110.037192","volume":"39","author":"SJ Miyagi","year":"2011","unstructured":"Miyagi SJ, Collier AC (2011) The development of UDP-glucuronosyltransferases 1A1 and 1A6 in the pediatric liver. Drug metabolism and disposition: the biological fate of chemicals 39(5):912\u2013919","journal-title":"Drug metabolism and disposition: the biological fate of chemicals"},{"issue":"9","key":"3080_CR29","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1016\/S0006-2952(03)00076-5","volume":"65","author":"BT Ethell","year":"2003","unstructured":"Ethell BT, Anderson GD, Burchell B (2003) The effect of valproic acid on drug and steroid glucuronidation by expressed human UDP-glucuronosyltransferases. Biochem Pharmacol 65(9):1441\u20131449","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"3080_CR30","first-page":"50","volume":"21","author":"T Ebner","year":"1993","unstructured":"Ebner T, Burchell B (1993) Substrate specificities of two stably expressed human liver UDP-glucuronosyltransferases of the UGT1 gene family. Drug metabolism and disposition: the biological fate of chemicals 21(1):50\u201355","journal-title":"Drug metabolism and disposition: the biological fate of chemicals"},{"issue":"1","key":"3080_CR31","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1046\/j.1365-2710.1999.00202.x","volume":"24","author":"BB Serrano","year":"1999","unstructured":"Serrano BB, Garc\u00eda S\u00e1nchez MJ, Otero MJ, Buelga DS, Serrano J, Dom\u00ednguez-Gil A (1999) Valproate population pharmacokinetics in children. J Clin Pharm Ther 24(1):73\u201380","journal-title":"J Clin Pharm Ther"},{"issue":"6","key":"3080_CR32","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/j.clinthera.2017.04.005","volume":"39","author":"J Methaneethorn","year":"2017","unstructured":"Methaneethorn J (2017) Population pharmacokinetics of valproic acid in patients with mania: implication for individualized dosing regimens. Clin Ther 39(6):1171\u20131181","journal-title":"Clin Ther"},{"issue":"11","key":"3080_CR33","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1007\/s00228-003-0699-7","volume":"59","author":"ES El Desoky","year":"2004","unstructured":"El Desoky ES, Fuseau E, El Din AS, Cosson V (2004) Pharmacokinetic modelling of valproic acid from routine clinical data in Egyptian epileptic patients. Eur J Clin Pharmacol 59(11):783\u2013790","journal-title":"Eur J Clin Pharmacol"},{"issue":"5\u20136","key":"3080_CR34","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1007\/s10928-005-0083-6","volume":"32","author":"JE Ahn","year":"2005","unstructured":"Ahn JE, Birnbaum AK, Brundage RC (2005) Inherent correlation between dose and clearance in therapeutic drug monitoring settings: possible misinterpretation in population pharmacokinetic analyses. J Pharmacokinet Pharmacodyn 32(5\u20136):703\u2013718","journal-title":"J Pharmacokinet Pharmacodyn"},{"issue":"2","key":"3080_CR35","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S0009-9236(96)90130-7","volume":"60","author":"GD Anderson","year":"1996","unstructured":"Anderson GD, Yau MK, Gidal BE, Harris SJ, Levy RH, Lai AA, Wolf KB, Wargin WA, Dren AT (1996) Bidirectional interaction of valproate and lamotrigine in healthy subjects. Clin Pharmacol Ther 60(2):145\u2013156","journal-title":"Clin Pharmacol Ther"},{"issue":"5","key":"3080_CR36","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1111\/bcp.13510","volume":"84","author":"J Methaneethorn","year":"2018","unstructured":"Methaneethorn J (2018) A systematic review of population pharmacokinetics of valproic acid. Br J Clin Pharmacol 84(5):816\u2013834","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"3080_CR37","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1097\/01.mjt.0000155113.89092.58","volume":"13","author":"D Panomvana Na Ayudhya","year":"2006","unstructured":"Panomvana Na Ayudhya D, Suwanmanee J, Visudtibhan A (2006) Pharmacokinetic parameters of total and unbound valproic acid and their relationships to seizure control in epileptic children. American journal of therapeutics 13(3):211\u2013217","journal-title":"American journal of therapeutics"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-020-03080-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00228-020-03080-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-020-03080-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T08:21:19Z","timestamp":1697530879000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00228-020-03080-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,10]]},"references-count":37,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["3080"],"URL":"https:\/\/doi.org\/10.1007\/s00228-020-03080-y","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,10]]},"assertion":[{"value":"24 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study protocol was performed in accordance with the guidelines of the Declaration of Helsinki (the 2013 version) and was approved by the Ethics Committee of Xiangya Hospital, and written informed consent was obtained from all patients\u2019 guardians.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All guardians signed a consent form on the behalf of the child to participate in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All guardians signed written informed consent document and agreed to publish the relevant data.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The code used in this study may be obtained from the corresponding author upon reasonable request.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}}]}}